GuizhouPeople’s Republic of ChinaAsi aCOVID-19COVID-19 ModelCoronavirusCyborgsDiagnostics and ScreeningDi sease ModelEmerging TechnologiesEpidemiologyGeneticsImmunologyMachine LearningMortalityPathogenesisRNA VirusesRisk and PreventionSARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus 2TestingViralVirology
2024